Our values
We are a patient-centric, collaborative organization that is driven to change the way cancer is treated. We are agile in our thinking and strive for excellence and innovation while acting with high integrity to create value for all stakeholders.
Patient-centricity – Our passion and purpose are to deliver personalized cell therapies to patients in need as quickly and efficiently as possible.
Integrity – We are an ethical, honest and transparent organization. We hold ourselves accountable to perform our individual responsibilities with the highest quality and integrity.
Agility – We are open-minded, flexible and data-driven. In the face of setbacks, we adapt.
Innovation – We apply our knowledge and learnings to further innovate and drive next-generation therapies and technologies.
Collaboration – Our success depends on effective teamwork, open communication, listening, respect and support for each other in achieving our goals.
Excellence – We are committed to meeting or exceeding our goals through quality work and clearly defined parameters for success. We are dedicated, tenacious and thorough, bringing our best efforts every day.
TIL therapy is an investigational therapy and has not been approved for any indication by the Food and Drug Administration (FDA) or any other regulatory agency. The safety and efficacy of this therapy have not been determined.